Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Impact of obesity on the clinical profile of a population-based sample with chronic obstructive pulmonary disease.

García-Rio F, Soriano JB, Miravitlles M, Muñoz L, Duran-Tauleria E, Sánchez G, Sobradillo V, Ancochea J.

PLoS One. 2014 Aug 25;9(8):e105220. doi: 10.1371/journal.pone.0105220. eCollection 2014.

2.

Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status.

Miravitlles M, Soriano JB, Ancochea J, Muñoz L, Duran-Tauleria E, Sánchez G, Sobradillo V, García-Río F.

Respir Med. 2013 Jul;107(7):1053-60. doi: 10.1016/j.rmed.2013.03.007. Epub 2013 Apr 16.

3.

Frequency of multi-dimensional COPD indices and relation with disease activity markers.

García-Rio F, Soriano JB, Miravitlles M, Muñoz L, Duran-Tauleria E, Sánchez G, Sobradillo V, Ancochea J.

COPD. 2013 Aug;10(4):436-43. doi: 10.3109/15412555.2012.761959. Epub 2013 Mar 28.

PMID:
23537163
4.

Underdiagnosis of chronic obstructive pulmonary disease in women: quantification of the problem, determinants and proposed actions.

Ancochea J, Miravitlles M, García-Río F, Muñoz L, Sánchez G, Sobradillo V, Duran-Tauleria E, Soriano JB.

Arch Bronconeumol. 2013 Jun;49(6):223-9. doi: 10.1016/j.arbres.2012.11.010. Epub 2013 Jan 12. English, Spanish.

5.

Spirometrically-defined restrictive ventilatory defect: population variability and individual determinants.

Soriano JB, Miravitlles M, García-Río F, Muñoz L, Sánchez G, Sobradillo V, Durán E, Guerrero D, Ancochea J.

Prim Care Respir J. 2012 Jun;21(2):187-93. doi: 10.4104/pcrj.2012.00027.

6.

Overdiagnosing subjects with COPD using the 0.7 fixed ratio: correlation with a poor health-related quality of life.

García-Rio F, Soriano JB, Miravitlles M, Muñoz L, Duran-Tauleria E, Sánchez G, Sobradillo V, Ancochea J.

Chest. 2011 May;139(5):1072-1080. doi: 10.1378/chest.10-1721. Epub 2010 Dec 23.

PMID:
21183609
7.

Systemic inflammation in chronic obstructive pulmonary disease: a population-based study.

Garcia-Rio F, Miravitlles M, Soriano JB, Muñoz L, Duran-Tauleria E, Sánchez G, Sobradillo V, Ancochea J; EPI-SCAN Steering Committee.

Respir Res. 2010 May 25;11:63. doi: 10.1186/1465-9921-11-63.

8.

Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities.

Miravitlles M, Soriano JB, García-Río F, Muñoz L, Duran-Tauleria E, Sanchez G, Sobradillo V, Ancochea J.

Thorax. 2009 Oct;64(10):863-8. doi: 10.1136/thx.2009.115725. Epub 2009 Jun 23.

PMID:
19553233
9.

[The EPI-SCAN survey to assess the prevalence of chronic obstructive pulmonary disease in Spanish 40-to-80-year-olds: protocol summary].

Ancochea J, Badiola C, Duran-Tauleria E, Garcia Rio F, Miravitlles M, Muñoz L, Sobradillo V, Soriano JB.

Arch Bronconeumol. 2009 Jan;45(1):41-7. doi: 10.1016/j.arbres.2008.06.001. Epub 2009 Jan 3. Spanish.

10.

[Assessment of patient satisfaction and preferences with inhalers in asthma with the FSI-10 Questionnaire].

Perpiñá Tordera M, Viejo JL, Sanchis J, Badia X, Cobos N, Picado C, Sobradillo V, Martínez González del Río J, Duce F, Muñoz Cabrera L.

Arch Bronconeumol. 2008 Jul;44(7):346-52. Spanish.

11.

Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers.

Miravitlles M, Ferrer M, Pont A, Luis Viejo J, Fernando Masa J, Gabriel R, Jiménez-Ruiz CA, Villasante C, Fernández-Fau L, Sobradillo V.

Respir Med. 2005 Aug;99(8):985-95. Epub 2005 Mar 4.

12.

[Smoking habits among sixth-year medical students in Spain].

Mas A, Nerín I, Barrueco M, Cordero J, Guillén D, Jiménez-Ruiz C, Sobradillo V.

Arch Bronconeumol. 2004 Sep;40(9):403-8. Spanish.

13.

Can cumulative tobacco consumption, FTND score, and carbon monoxide concentration in expired air be predictors of chronic obstructive pulmonary disease?

Jiménez-Ruiz C, Miravitlles M, Sobradillo V, Gabriel R, Viejo JL, Masa JF, Fernández-Fau L, Villasante C.

Nicotine Tob Res. 2004 Aug;6(4):649-53.

PMID:
15370161
14.

[Costs of chronic obstructive pulmonary disease in Spain. Estimation from a population-based study].

Masa JF, Sobradillo V, Villasante C, Jiménez-Ruiz CA, Fernández-Fau L, Viejo JL, Miravitlles M.

Arch Bronconeumol. 2004 Feb;40(2):72-9. Spanish.

15.

[Second consensus report on the use of antimicrobial agents in exacerbations of chronic obstructive pulmonary disease].

Alvarez F, Bouza E, García-Rodríguez JA, Mensa J, Monsó E, Picazo JJ, Sobradillo V, Torres A, Moya Mir M, Martínez Ortiz De Zárate M, Pérez Escanilla F, Puente T, Cañada JL.

Arch Bronconeumol. 2003 Jun;39(6):274-82. Spanish.

16.

Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma.

Vaquerizo MJ, Casan P, Castillo J, Perpiña M, Sanchis J, Sobradillo V, Valencia A, Verea H, Viejo JL, Villasante C, Gonzalez-Esteban J, Picado C; CASIOPEA (Capacidad de Singulair Oral en la Prevencion de Exacerbaciones Asmaticas) Study Group.

Thorax. 2003 Mar;58(3):204-10. Erratum in: Thorax. 2003 Apr;58(4):370.

17.

[Second consensus statement on the use of antimicrobial drugs in chronic obstructive pulmonary disease exacerbations].

Alvarez F, Bouza E, García-Rodríguez JA, Mensa J, Picazo JJ, Sobradillo V, Torres A, Moya Mir M, Martínez Ortiz de Zárate M, Pérez Escanilla F, Puente T, Cañada JL.

Rev Esp Quimioter. 2002 Dec;15(4):375-85. Spanish. No abstract available.

18.

[Accreditation requirements for educational programs in respiratory medicine].

Alvarez-Sala JL, Sánchez Gascón F, Agustí A, Díaz Cambriles MT, Gómez de Terreros FJ, Lozano L, Miravitlles M, Rodríguez de Castro F, Sobradillo V, Viejo JL, Villamor J.

Arch Bronconeumol. 2003 Jan;39(1):42-4. Spanish. No abstract available.

19.

[Respiratory symptoms and diagnosis of COPD in smokers of various types to tobacco. Results from the IBERPOC study].

Jiménez-Ruiz CA, Sobradillo V, Gabriel R, Viejo JL, Masa JF, Miravitlles M, Villasante C, Fernández-Fau L.

Arch Bronconeumol. 2002 Nov;38(11):530-5. Spanish.

20.

[2002: a good year for turning approach to COPD around].

Rodríguez Roisin R, Alvarez-Sala JL, Sobradillo V.

Arch Bronconeumol. 2002 Nov;38(11):503-5. Spanish. No abstract available.

21.

[Spirometry: quality in the respiratory medicine clinics of a public health care area].

López de Santa María E, Gutiérrez L, Legórburu C, Valero M, Zabala M, Sobradillo V, Gáldiz JB.

Arch Bronconeumol. 2002 May;38(5):204-8. Spanish.

22.

Interpretation of quality of life scores from the St George's Respiratory Questionnaire.

Ferrer M, Villasante C, Alonso J, Sobradillo V, Gabriel R, Vilagut G, Masa JF, Viejo JL, Jiménez-Ruiz CA, Miravitlles M.

Eur Respir J. 2002 Mar;19(3):405-13.

23.

[Antimicrobial therapy in exacerbated chronic obstructive pulmonary disease].

Alvarez F, Bouza E, García-Rodríguez JA, Mayer MA, Mensa J, Monsó E, Nodar E, Picazo JJ, Sobradillo V, Torres A; Sociedad Española de Neumología y Cirugía Torácica (SEPAR).

Arch Bronconeumol. 2002 Feb;38(2):81-9. Review. Spanish. No abstract available.

24.

[Early discharge and home health care program for patients with exacerbated COPD and asthma].

Antoñana J, Sobradillo V, De Marcos D, Chic S, Galdiz J, Iriberri M.

Arch Bronconeumol. 2001 Dec;37(11):489-94. Spanish.

25.

[Use of antibiotics in exacerbated chronic obstructive pulmonary disease].

Alvarez F, Bouza E, García-Rodríguez JA, Mayer MA, Mensa J, Monsó E, Nodar E, Picazo JJ, Sobradillo V, Torres A.

Aten Primaria. 2001 Oct 15;28(6):415-24. Review. Spanish. No abstract available.

26.

[Use of antibiotics in the exacerbation of chronic obstructive pulmonary disease].

Alvarez F, Bouza E, García-Rodríguez JA, Mayer MA, Mensa J, Monsó E, Nodar E, Picazo JJ, Sobradillo V, Torres A.

Rev Esp Quimioter. 2001 Mar;14(1):87-96. Review. Spanish. No abstract available.

PMID:
11376355
27.

Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD.

Jiménez-Ruiz CA, Masa F, Miravitlles M, Gabriel R, Viejo JL, Villasante C, Sobradillo V.

Chest. 2001 May;119(5):1365-70.

PMID:
11348940
28.

[Compliance with inhalation treatment of patients with chronic obstructive pulmonary disease].

Viejo JL, Martín Escribano P, Romero S, Rodríguez Suárez JR, Sobradillo V, Valencia A.

Arch Bronconeumol. 2000 Jun;36(6):319-25. Spanish.

29.

[Prevalence of and attitudes towards smoking in a population over 40 years of age].

Jiménez Ruiz CA, Fernando Masa J, Sobradillo V, Gabriel R, Miravitlles M, Fernández-Fau L, Villasante C, Viejo JL.

Arch Bronconeumol. 2000 May;36(5):241-4. Spanish.

30.

[The internal consistency and content validity of the Spanish version of the Asthma Autonomy Questionnaire].

Perpiñá M, Sobradillo V, Castillo J, Duce F, Manresa F, Martínez J, Valencia A, Viejo JL, Villasante C.

Arch Bronconeumol. 2000 Feb;36(2):90-4. Spanish.

31.

[Asthma emergencies: can we lower the rate of readmission after discharge?].

Campo A, Galdiz JB, Iriberri M, Pascal I, Sobradillo V.

Arch Bronconeumol. 1999 Dec;35(11):529-34. Spanish.

PMID:
10687036
32.

[Information seeking and decision making in asthmatic patients].

Perpiñá M, Sobradillo V, Castillo J, Duce F, Manresa F, Martínez J, Valencia A, Viejo JL, Villasante C.

Arch Bronconeumol. 1999 Oct;35(9):435-9. Spanish.

PMID:
10596340
33.

[The role of the new quinolones in the treatment and prevention of tuberculosis and other infections caused by mycobacterium].

Ciruelos E, Zalazaín R, Sobradillo V.

Enferm Infecc Microbiol Clin. 1999;17 Suppl 1:34-8. Review. Spanish. No abstract available.

PMID:
10563109
34.

[Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): prevalence of chronic respiratory symptoms and airflow limitation].

Sobradillo V, Miravitlles M, Jiménez CA, Gabriel R, Viejo JL, Masa JF, Fernández-Fau L, Villasante C.

Arch Bronconeumol. 1999 Apr;35(4):159-66. Spanish.

PMID:
10330536
35.

[Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): recruitment and field work].

Miravitlles M, Sobradillo V, Villasante C, Gabriel R, Masa JF, Jiménez CA, Fernández-Fau L, Viejo JL.

Arch Bronconeumol. 1999 Apr;35(4):152-8. Spanish.

PMID:
10330535
36.

Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease.

Zalacain R, Sobradillo V, Amilibia J, Barrón J, Achótegui V, Pijoan JI, Llorente JL.

Eur Respir J. 1999 Feb;13(2):343-8.

37.

Low-dose formoterol Turbuhaler (Oxis) b.i.d., a 3-month placebo-controlled comparison with terbutaline (q.i.d.).

Ekström T, Ringdal N, Sobradillo V, Runnerström E, Soliman S.

Respir Med. 1998 Aug;92(8):1040-5.

38.

[Usefulness of computerized tomography in the study of pleural effusion with no presumed diagnosis].

Cabriada V, Antoñana JM, Sobradillo V, Pascal I, Gáldiz JB, Peña JM.

Arch Bronconeumol. 1997 Nov;33(10):503-8. Spanish.

PMID:
9453817
39.

[Double-blind clinical trial comparing 5 days of dirithromycin versus 7 days of diacetylmidecamycin in acute bronchitis and acute exacerbations of chronic bronchitis].

Sacristán JA, Elviro J, García de Lomas J, Palomino-Nicás J, Sobradillo V, Sánchez Gascón F, Valencia A, Calbo F, Viejo JL, Zamarrón C, Coca E, Casado MA, García Pérez LE, Hernández JM.

Enferm Infecc Microbiol Clin. 1997 Aug-Sep;15(7):357-60. Spanish.

PMID:
9410047
40.

[Community acquired pneumonia. Reliability of the criteria for deciding ambulatory treatment].

Zalacain R, Talayero N, Achótegui V, Corral J, Barreña I, Sobradillo V.

Arch Bronconeumol. 1997 Feb;33(2):74-9. Spanish.

PMID:
9091117
41.

[Protected bacteriologic brushing in patients with severe copd].

Zalacain R, Achótegui V, Pascal I, Camino J, Barrón J, Sobradillo V.

Arch Bronconeumol. 1997 Jan;33(1):16-9. Spanish.

PMID:
9072127
42.

[Current use, methodology and evaluation of nonspecific bronchial provocation tests in our country].

Pellicer C, Galdiz B, Perpiña M, de Diego A, Sobradillo V.

Arch Bronconeumol. 1995 Jan;31(1):6-12. Spanish.

PMID:
7881724
43.

Influence of three factors on the diagnostic effectiveness of transthoracic needle aspiration in pneumonia.

Zalacain R, Llorente JL, Gaztelurrutia L, Pijoan JI, Sobradillo V.

Chest. 1995 Jan;107(1):96-100.

PMID:
7813320
44.

[Pneumonia in alcoholic patients: the clinical and etiological characteristics].

Llorente JL, Zalacaín R, Gaztelurrutia L, Talayero N, Antoñana JM, Sobradillo V.

Arch Bronconeumol. 1994 Mar;30(3):136-40. Spanish.

PMID:
8186905
45.

[Clinical and etiological features of community-acquired pneumonia in the elderly].

Llorente JL, Zalacaín R, Gaztelurrutia L, Talayero N, Pérez M, Badiola C, Sobradillo V.

Enferm Infecc Microbiol Clin. 1994 Jan;12(1):21-5. Spanish.

PMID:
8155750
46.

[Transthoracic aspiration punction with ultrafine needle in high risk community acquired pneumonia].

Zalacaín R, Llorente JL, Gaztelurrutia L, Zenarruzabeitia E, Uresandi F, Sobradillo V.

Med Clin (Barc). 1993 Apr 17;100(15):567-70. Spanish.

PMID:
8497144
47.

Antibiotic treatment in pneumonia due to Q fever.

Sobradillo V, Zalacain R, Capelastegui A, Uresandi F, Corral J.

Thorax. 1992 Apr;47(4):276-8.

48.

[A multicenter study of the breaking of the smoking habit with nicotine chewing gum in health personnel].

Agustí A, Estopá R, González J, Guerra D, Marín D, Roig P, Salvador T, Sánchez L, Sobradillo V, Bartlett A, et al.

Med Clin (Barc). 1991 Oct 26;97(14):526-30. Spanish.

PMID:
1753826
49.

[Pleural effusion associated with primary lymphedema: a rare combination. Apropos of a case].

Casado Y, Uresandi F, Montes MT, Llorente JL, Sobradillo V.

Med Clin (Barc). 1990 Jun 23;95(4):141-2. Review. Spanish.

PMID:
2250535
50.

Q fever pneumonia: a review of 164 community-acquired cases in the Basque country.

Sobradillo V, Ansola P, Baranda F, Corral C.

Eur Respir J. 1989 Mar;2(3):263-6.

PMID:
2731605

Supplemental Content

Loading ...
Support Center